Overview
What It Is Transcranial Direct Current Stimulation (tDCS) delivers a low-intensity, constant electrical current through scalp electrodes to gently increase or decrease cortical excitability in targeted regions. Sessions typically last 20–30 minutes and are often paired with therapy exercises. Clinic devices and some supervised home systems exist.
How It Works Weak electrical current biases neurons toward firing more or less easily. When stimulation is paired with skill practice (e.g., motor therapy after stroke or cognitive exercises), it may support use-dependent plasticity by making practice-related networks more or less excitable. Effects are protocol- and target-dependent and usually modest alone.
On-label / regulatory status - Most clinical uses remain investigational or off-label in the U.S.; regulatory status varies by country and device - Not equivalent to FDA-cleared rTMS depression protocols - Sometimes used under research protocols or specialist supervision for depression, stroke recovery, pain, and cognition
Off-label / research uses - Post-stroke motor or language therapy augmentation - Depression and cognitive symptoms (mixed evidence) - Chronic pain and migraine (mixed) - Parkinson’s and other neurologic applications under study
Conditions - Explored for: stroke and TBI rehabilitation support, depression, persistent pain, and cognitive symptoms - Best considered an adjunct to active therapy or clinical care, not a stand-alone cure
How it is administered
Clinic or supervised home sessions. Electrodes on the scalp deliver a low-intensity current for about 20–30 minutes, often paired with therapy exercises.
Conditions connected in the NPA database
The NPA Treatment Database lists this treatment in connection with 5 condition records. A database relationship does not establish effectiveness, safety, or suitability for an individual.
Related questions
These controlled question pages reference this treatment through stored condition relationships.
- What treatments are listed for Clinical Depression in the NPA database?
- What treatments are listed for Parkinson's Disease (PD) in the NPA database?
- What treatments are listed for Persistent Pain in the NPA database?
- What treatments are listed for Stroke in the NPA database?
- What treatments are listed for Traumatic Brain Injury (TBI) in the NPA database?
Symptoms connected in the NPA database
The current record associates this treatment with the following symptom information. This is not a claim that the treatment will improve these symptoms.
Cognition & Memory
- difficulty concentrating
- Difficulty concentrating (“brain fog”)
- indecisiveness
- Later memory and thinking changes
- memory complaints
- mental fog
- Short-term memory issues
- Short-term memory problems
- slowed mental processing
- slowed processing
- slowed thinking
- spatial neglect
Emotion & Behavior
- anxiety
- apathy
- Depression
- emotional lability (uncontrollable laughing/crying)
- feelings of worthlessness
- frustration
- impulsivity
- irritability
- loss of interest/pleasure
- mood changes
- mood swings
- Persistent sadness
- social withdrawal
Motor Control
- Balance and coordination problems
- balance and gait problems
- difficulty walking
- guarding
- muscle stiffness/spasticity
- muscle tension
- One-sided weakness or paralysis
- poor balance and coordination
- reduced fine motor skills
- Reduced mobility
- rigidity/stiffness
- slowed movement (bradykinesia)
- slowed movements
- Slowed movements or restlessness (psychomotor changes)
- Tremor
- weakness
Sensory & Pain
- central post-stroke pain (burning, shooting pain, and sensitivity to touch, temperature)
- headaches
- heightened sensitivity
- Numbness or altered sensation
- numbness or tingling
- Pain
- Persistent headaches
- Persistent pain (aching, burning, stabbing)
- reduced sense of smell
- sensitivity to light/noise
- sensory changes
- tinnitus
- Unexplained aches and pains
Sleep & Fatigue
- Excessive fatigue
- fatigue
- Insomnia or excessive sleepiness
- Insomnia or hypersomnia
- profound fatigue and low energy
- profound physical and mental fatigue
- Sleep disruption due to pain
- sleep disturbances
- Sleep problems (including REM sleep behavior disorder)
Practical information
Insurance coverage
Rarely covered; usually experimental or out-of-pocket.
Cost information
Devices $200–$1,000+; clinic sessions vary.
Results and outcomes described in the source record
Some effects during or shortly after sessions; cumulative benefits over weeks.
Side effects and risks
Mild skin irritation, tingling, or headache common. Rare more significant effects if improperly used.
Research context in the NPA database
This section reproduces the current database's research summary and detail. Structured citation metadata has not been supplied, so it should not be read as an independently verified literature review.
Research summary
Evidence Level: Emerging to Moderate (varies by indication) What the research shows: Meta-analyses show small-to-moderate effects for some depression and post-stroke motor protocols when paired with training; results are inconsistent across studies. Not a first-line replacement for established therapies. Key takeaway: A low-intensity, non-invasive adjunct that may boost practice effects in selected protocols; expectations should stay modest.
Research detail
Overview Transcranial Direct Current Stimulation delivers a low-intensity, constant electrical current through electrodes on the scalp to gently increase or decrease cortical excitability in targeted regions. Sessions typically last 20–30 minutes and are often combined with therapy. Home or clinic devices are available. Research supports tDCS (often paired with therapy) for motor recovery after stroke and for major depression; data for ADHD and autism are emerging.
Evidence Base and Published Work • Randomized controlled trials support tDCS (often paired with therapy) for motor recovery after stroke and for major depression. • Systematic reviews of tDCS applications document moderate evidence for these indications; data for ADHD and autism are emerging. • Key published work includes: – RCTs in post-stroke motor recovery and depression. – Systematic reviews of tDCS applications. – Emerging trials in ADHD and autism. – Side effects are usually mild (skin irritation, tingling, headache). Seizure risk is very low with proper screening and parameters. Evidence is moderate and varies by condition; best results often occur when stimulation is combined with active skill practice.
Outcomes Outcomes most frequently described include motor recovery benefits after stroke and mood effects in depression when paired with therapy. Evidence is moderate and varies by condition.
Questions to ask a provider
1. Is tDCS appropriate for my motor recovery or depression goals, and will it be paired with therapy? 2. What electrode placement and stimulation parameters will be used? 3. How many sessions are recommended, and can any of the treatment be done at home? 4. What side effects (skin irritation, tingling, headache) are common, and who should not receive tDCS? 5. Is clinical tDCS covered by insurance, or is it primarily self-pay?
Explore the interactive Treatment Database
Continue to compare educational treatment information in the interactive database. The standard disclaimer acknowledgement is required before the database opens.
Explore treatment information in the database